Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$206,086,114
+$13,299,716 QoQ
Shares Held
818,972
-7.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
3.46%
of 13F equity value
Holder Rank
#157
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. ABBV ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $206,086,114 | 818,972 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $192,786,398 | 886,415 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $204,173,180 | 893,576 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $210,863,246 | 910,699 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $167,576,436 | 902,793 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $194,443,569 | 928,043 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $170,558,237 | 959,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $187,759,639 | 950,778 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $165,489,356 | 964,840 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $174,093,427 | 956,032 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $152,947,176 | 986,947 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $149,248,560 | 1,001,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $133,863,955 | 993,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $156,607,639 | 982,667 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $163,985,182 | 1,014,697 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $139,031,360 | 1,035,924 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $159,393,458 | 1,040,699 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $190,002,484 | 1,172,059 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $165,656,890 | 1,223,463 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $132,275,156 | 1,226,246 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $136,119,695 | 1,208,449 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $121,320,896 | 1,121,058 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $113,791,157 | 1,061,980 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $91,191,438 | 1,041,117 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $103,093,319 | 1,050,044 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $82,441,922 | 1,082,057 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||